Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1996 Sep;86(9):1281–1288. doi: 10.2105/ajph.86.9.1281

Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.

P A Schulte 1, C A Burnett 1, M F Boeniger 1, J Johnson 1
PMCID: PMC1380592  PMID: 8806381

Abstract

OBJECTIVES: To identify potential occupational risk factors, this study examined the occupational occurrence of various neurodegenerative diseases. METHODS: Death certificates from 27 states in the National Occupational Mortality Surveillance System were evaluated for 1982 to 1991. Proportionate mortality ratios were calculated by occupation for presenile dementia, Alzheimer's disease, Parkinson's disease, and motor neuron disease. RESULTS: Excess mortality was observed for all four categories in the following occupational categories: teachers; medical personnel; machinists and machine operators; scientists; writers/designers/entertainers; and support and clerical workers. Clusters of three neurodegenerative diseases were also found in occupations involving pesticides, solvents, and electromagnetic fields and in legal, library, social, and religious work. Early death from motor neuron disease was found for firefighters, janitors, military personnel, teachers, excavation machine operators, and veterinarians, among others. CONCLUSIONS: Neurodegenerative disease occurs more frequently in some occupations than in others, and this distribution, which may indicate occupational risk factors, should be further investigated.

Full text

PDF
1281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpérovitch A., Hauw J. J. Neuropathological diagnoses in epidemiologic studies. Neuroepidemiology. 1992;11 (Suppl 1):100–105. doi: 10.1159/000110999. [DOI] [PubMed] [Google Scholar]
  2. Angunawela I. I., Diwan V. K., Tomson G. Experimental evaluation of the effects of drug information on antibiotic prescribing: a study in outpatient care in an area of Sri lanka. Int J Epidemiol. 1991 Jun;20(2):558–564. doi: 10.1093/ije/20.2.558. [DOI] [PubMed] [Google Scholar]
  3. Appel S. H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease. Ann Neurol. 1981 Dec;10(6):499–505. doi: 10.1002/ana.410100602. [DOI] [PubMed] [Google Scholar]
  4. Baron J. A. Cigarette smoking and Parkinson's disease. Neurology. 1986 Nov;36(11):1490–1496. doi: 10.1212/wnl.36.11.1490. [DOI] [PubMed] [Google Scholar]
  5. Beard C. M., Kokmen E., Offord K. P., Kurland L. T. Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement. Neurology. 1992 Nov;42(11):2063–2068. doi: 10.1212/wnl.42.11.2063. [DOI] [PubMed] [Google Scholar]
  6. Blair A., Dosemeci M., Heineman E. F. Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med. 1993 May;23(5):729–742. doi: 10.1002/ajim.4700230507. [DOI] [PubMed] [Google Scholar]
  7. Bocchetta A., Corsini G. U. Parkinson's disease and pesticides. Lancet. 1986 Nov 15;2(8516):1163–1163. doi: 10.1016/s0140-6736(86)90576-3. [DOI] [PubMed] [Google Scholar]
  8. Calne D. B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet. 1986 Nov 8;2(8515):1067–1070. doi: 10.1016/s0140-6736(86)90469-1. [DOI] [PubMed] [Google Scholar]
  9. Calne D. B., Hochberg F. H., Snow B. J., Nygaard T. Theories of neurodegeneration. Ann N Y Acad Sci. 1992 May 11;648:1–5. doi: 10.1111/j.1749-6632.1992.tb24518.x. [DOI] [PubMed] [Google Scholar]
  10. Campbell A. M., Williams E. R., Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877–885. doi: 10.1136/jnnp.33.6.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chancellor A. M., Slattery J. M., Fraser H., Warlow C. P. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1200–1206. doi: 10.1136/jnnp.56.11.1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chió A., Meineri P., Tribolo A., Schiffer D. Risk factors in motor neuron disease: a case-control study. Neuroepidemiology. 1991;10(4):174–184. doi: 10.1159/000110267. [DOI] [PubMed] [Google Scholar]
  13. Dartigues J. F., Gagnon M., Mazaux J. M., Barberger-Gateau P., Commenges D., Letenneur L., Orgogozo J. M. Occupation during life and memory performance in nondemented French elderly community residents. Neurology. 1992 Sep;42(9):1697–1701. doi: 10.1212/wnl.42.9.1697. [DOI] [PubMed] [Google Scholar]
  14. Davanipour Z., Sobel E., Vu H., Will A. D. Electromagnetic field exposure and amyotrophic lateral sclerosis. Neuroepidemiology. 1991;10(5-6):308–308. doi: 10.1159/000110288. [DOI] [PubMed] [Google Scholar]
  15. Dawson R., Jr, Beal M. F., Bondy S. C., Di Monte D. A., Isom G. E. Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol Appl Pharmacol. 1995 Sep;134(1):1–17. doi: 10.1006/taap.1995.1163. [DOI] [PubMed] [Google Scholar]
  16. Deapen D. M., Henderson B. E. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol. 1986 May;123(5):790–799. doi: 10.1093/oxfordjournals.aje.a114308. [DOI] [PubMed] [Google Scholar]
  17. Fleming L., Mann J. B., Bean J., Briggle T., Sanchez-Ramos J. R. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol. 1994 Jul;36(1):100–103. doi: 10.1002/ana.410360119. [DOI] [PubMed] [Google Scholar]
  18. Gawel M., Zaiwalla Z., Rose F. C. Antecedent events in motor neuron disease. J Neurol Neurosurg Psychiatry. 1983 Nov;46(11):1041–1043. doi: 10.1136/jnnp.46.11.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Godwin-Austen R. B., Lee P. N., Marmot M. G., Stern G. M. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):577–581. doi: 10.1136/jnnp.45.7.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Golbe L. I. Risk factors in young-onset Parkinson's disease. Neurology. 1993 Sep;43(9):1641–1643. doi: 10.1212/wnl.43.9.1641. [DOI] [PubMed] [Google Scholar]
  21. Goldacre M. J. Cause-specific mortality: understanding uncertain tips of the disease iceberg. J Epidemiol Community Health. 1993 Dec;47(6):491–496. doi: 10.1136/jech.47.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gunnarsson L. G., Bodin L., Söderfeldt B., Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med. 1992 Nov;49(11):791–798. doi: 10.1136/oem.49.11.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gállego J., Delgado G., Tuñn T., Villanueva J. A. Delayed postirradiation lower motor neuron syndrome. Ann Neurol. 1986 Mar;19(3):308–309. doi: 10.1002/ana.410190321. [DOI] [PubMed] [Google Scholar]
  24. Hertzman C., Wiens M., Snow B., Kelly S., Calne D. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord. 1994 Jan;9(1):69–75. doi: 10.1002/mds.870090111. [DOI] [PubMed] [Google Scholar]
  25. Hubble J. P., Cao T., Hassanein R. E., Neuberger J. S., Koller W. C. Risk factors for Parkinson's disease. Neurology. 1993 Sep;43(9):1693–1697. doi: 10.1212/wnl.43.9.1693. [DOI] [PubMed] [Google Scholar]
  26. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology. 1993 Jan;43(1):13–20. doi: 10.1212/wnl.43.1_part_1.13. [DOI] [PubMed] [Google Scholar]
  27. Kondo K., Tsubaki T. Case-control studies of motor neuron disease: association with mechanical injuries. Arch Neurol. 1981 Apr;38(4):220–226. doi: 10.1001/archneur.1981.00510040046007. [DOI] [PubMed] [Google Scholar]
  28. Kurtzke J. F., Murphy F. M. The changing patterns of death rates in parkinsonism. Neurology. 1990 Jan;40(1):42–49. doi: 10.1212/wnl.40.1.42. [DOI] [PubMed] [Google Scholar]
  29. Langston J. W., Ballard P. A., Jr Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med. 1983 Aug 4;309(5):310–310. doi: 10.1056/nejm198308043090511. [DOI] [PubMed] [Google Scholar]
  30. Langston J. W., Ballard P., Tetrud J. W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983 Feb 25;219(4587):979–980. doi: 10.1126/science.6823561. [DOI] [PubMed] [Google Scholar]
  31. Lee P. N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology. 1994;13(4):131–144. doi: 10.1159/000110372. [DOI] [PubMed] [Google Scholar]
  32. Lilienfeld D. E., Chan E., Ehland J., Godbold J., Landrigan P. J., Marsh G., Perl D. P. Rising mortality from motoneuron disease in the USA, 1962-84. Lancet. 1989 Apr 1;1(8640):710–713. doi: 10.1016/s0140-6736(89)92218-6. [DOI] [PubMed] [Google Scholar]
  33. Lilienfeld D. E., Perl D. P. Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040. Neuroepidemiology. 1994;13(4):179–186. doi: 10.1159/000110377. [DOI] [PubMed] [Google Scholar]
  34. Lilienfeld D. E., Perl D. P. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology. 1993;12(4):219–228. doi: 10.1159/000110320. [DOI] [PubMed] [Google Scholar]
  35. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  36. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M. X., Ginsberg H., Chun M., Tycko B., Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 1995 Mar;45(3 Pt 1):555–557. doi: 10.1212/wnl.45.3.555. [DOI] [PubMed] [Google Scholar]
  37. McDowall M. Adjusting proportional mortality ratios for the influence of extraneous causes of death. Stat Med. 1983 Oct-Dec;2(4):467–475. doi: 10.1002/sim.4780020405. [DOI] [PubMed] [Google Scholar]
  38. Murros K., Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand. 1983 Jan;67(1):41–47. doi: 10.1111/j.1600-0404.1983.tb04543.x. [DOI] [PubMed] [Google Scholar]
  39. Ngim C. H., Devathasan G. Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology. 1989;8(3):128–141. doi: 10.1159/000110175. [DOI] [PubMed] [Google Scholar]
  40. Paulson G. W., Dadmehr N. Is there a premorbid personality typical for Parkinson's disease? Neurology. 1991 May;41(5 Suppl 2):73–76. doi: 10.1212/wnl.41.5_suppl_2.73. [DOI] [PubMed] [Google Scholar]
  41. Pericak-Vance M. A., Haines J. L. Genetic susceptibility to Alzheimer disease. Trends Genet. 1995 Dec;11(12):504–508. doi: 10.1016/s0168-9525(00)89161-1. [DOI] [PubMed] [Google Scholar]
  42. Planté-Bordeneuve V., Davis M. B., Maraganore D. M., Marsden C. D., Harding A. E. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):911–913. doi: 10.1136/jnnp.57.8.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Riggs J. E., Schochet S. S., Jr Rising mortality due to Parkinson's disease and amyotrophic lateral sclerosis: a manifestation of the competitive nature of human mortality. J Clin Epidemiol. 1992 Sep;45(9):1007–1012. doi: 10.1016/0895-4356(92)90116-5. [DOI] [PubMed] [Google Scholar]
  44. Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology. 1992 Jul;42(7):1328–1335. doi: 10.1212/wnl.42.7.1328. [DOI] [PubMed] [Google Scholar]
  45. Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology. 1993 Jun;43(6):1173–1180. doi: 10.1212/wnl.43.6.1173. [DOI] [PubMed] [Google Scholar]
  46. Shalat S. L., Seltzer B., Baker E. L., Jr Occupational risk factors and Alzheimer's disease: a case-control study. J Occup Med. 1988 Dec;30(12):934–936. doi: 10.1097/00043764-198812000-00010. [DOI] [PubMed] [Google Scholar]
  47. Smith C. A., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maraganore D. M., Sturman S. G., Schapira A. H., Williams A. C., Maranganore D. M. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 1992 Jun 6;339(8806):1375–1377. doi: 10.1016/0140-6736(92)91196-f. [DOI] [PubMed] [Google Scholar]
  48. Spencer P. S., Ludolph A. C., Kisby G. E. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties? Ann N Y Acad Sci. 1992 May 11;648:154–160. doi: 10.1111/j.1749-6632.1992.tb24533.x. [DOI] [PubMed] [Google Scholar]
  49. Stern M., Dulaney E., Gruber S. B., Golbe L., Bergen M., Hurtig H., Gollomp S., Stolley P. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Arch Neurol. 1991 Sep;48(9):903–907. doi: 10.1001/archneur.1991.00530210029018. [DOI] [PubMed] [Google Scholar]
  50. Tanner C. M., Chen B., Wang W. Z., Peng M. L., Liu Z. L., Liang X. L., Kao L. C., Gilley D. W., Schoenberg B. S. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci. 1987 Aug;14(3 Suppl):419–423. doi: 10.1017/s0317167100037835. [DOI] [PubMed] [Google Scholar]
  51. Treves T. A., Chandra V., Korczyn A. D. Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects. Neuroepidemiology. 1993;12(6):336–344. doi: 10.1159/000110336. [DOI] [PubMed] [Google Scholar]
  52. Wang J. D., Huang C. C., Hwang Y. H., Chiang J. R., Lin J. M., Chen J. S. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989 Dec;46(12):856–859. doi: 10.1136/oem.46.12.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wang W. Z., Fang X. H., Cheng X. M., Jiang D. H., Lin Z. J. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology. 1993;12(4):209–218. doi: 10.1159/000110319. [DOI] [PubMed] [Google Scholar]
  54. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]
  55. White L., Katzman R., Losonczy K., Salive M., Wallace R., Berkman L., Taylor J., Fillenbaum G., Havlik R. Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol. 1994 Apr;47(4):363–374. doi: 10.1016/0895-4356(94)90157-0. [DOI] [PubMed] [Google Scholar]
  56. Wísniewski H. M., Robe A., Zigman W., Silverman W. Neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1989 Nov;48(6):606–609. doi: 10.1097/00005072-198911000-00001. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES